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The evidence of myocardium at potential ischemic risk on pre-
operative dipyridamole perfusion scintigraphy was compared with 
that of manifest ischemia on intraoperative transesophageal echo-
cardiography in 26 patients at high risk of a coronary event 
undergoing noncardiac surgery. The clinical outcome was also 
assessed. Induced intraoperative wall motion abnormalities were 
more common in patients and myocardial segments with, than in 
those without, a preoperative reversible perfusion defect (both 
p < 0.05). Conversely, a preoperative reversible perfusion defect 
was more common in patients and segments with, than in those 
without, a new intraoperative wall motion abnormality (both p < 
0.05). 
Six patients, five with a reversible scintigraphic defect but only 
three with a new wall motion abnormality, had a hard perioper-
at,ve ischemic event. Events occurred more often among patients 
Background. Intravenous dipyridamole infusion induces 
coronary vasodilation, providing a pathophysiologic test of 
coronary flow reserve, which can be visually assessed with 
myocardial perfusion imaging using thallium-201 (1-3). In 
several studies (4-6) this method has shown diagnostic 
accuracy for coronary artery disease comparable with that of 
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with, than in those without, a reversible perioperative scinti-
graphic defect (5 [33%) of 15 vs. 1 [9%) of 11) but this difference 
did not reach significance (p = 0.14), probably owing to the 
sample size. Intraoperative wall motion abnormalities were all 
reversible and did not differentiate between risk groups; these 
findings were possibly influenced by treatment. 
These preliminary data support the known relation between 
reversible scintigraphic defects and perioperative events and 
identify a!1other manifestation of ischemic risk in the relation 
between reversible scintigraphic defects and induced intraopera-
tive wall motion abnormalities. The value of intraoperative echo-
cardiography in identifying ischemia and guiding therapy in 
patients with a reversible scintigraphic abnormality should be 
further assessed. 
(J Am Coll CardioI1991;18:93-100) 
exercise scintigraphy. More recently, such pharmacologic 
studies (7-10) have demonstrated prognostic abilities for 
perioperative cardiac risk. 
Preoperative intravenous dipyridamole infusion permits 
noninvasive evaluation of coronary perfusion when exercise 
testing cannot be performed at levels sufficient for diagnosis 
or prognosis, or when exercise assessment is not possible 
owing to physical debility or handicap. Like exercise myo-
cardial perfusion imaging, dipyridamole infusion appears to 
be more physiologic than coronary angiography. Its applica-
tion to patients for whom dynamic exercise testing is pre-
cluded has permitted preoperative assessment of periopera-
tive cardiac risk. Preoperative' assessment is especially 
valuable in patients undergoing peripheral vascular surgery, 
in which the greatest operative risk appears to be related to 
ischemic coronary events. 
A reversible thallium defect on preoperative dipyrida-
mole perfusion imaging is indicative of myocardium at 
ischemic risk and is predictive of ischemic events after 
peripheral vascular and other noncardiac surgery (7-10). 
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This predictive value appears greatest when applied to a 
clinically high risk subset of patients (9). Scintigraphy also 
appears capable of identifying patients at low risk for peri-
operative ischemic events. Serious cardiac events are up to 
23 times more frequent in patients with a reversible thallium 
defect than in patients without such a defect (8). Although 
coronary risk assessment is probably more complicated than 
finding the simple relation between the presence of revers-
ible defects and events, dipyridamole perfusion scintigraphy 
nonetheless appears to have such a relation, a prognostic 
value capability not currently available by other means 
(7-12). Our ability to influence this prognosis has not yet 
been fully evaluated. 
Certainly, not every patient with a reversible defect 
demonstrates a postoperative coronary event (6-9). Did 
myocardial ischemia not materialize in these patients or was 
it transient and otherwise averted? How many such patients 
with a benign follow-up were, in fact, threatened by intra-
operative ischemia? An intraoperative assessment of in-
duced ischemia could address these questions and poten-
tially provide the link between myocardium identified to be 
at potential ischemic risk preoperatively and manifest peri-
operative ischemia. With use of intraoperative transesoph-
ageal echocardiographic assessment of myocardial wall 
motion (13), preoperative scintigraphic evidence of myocar-
dium at ischemic risk can be compared with the area of 
surgically induced ischemia. Do such surgically induced wall 
motion abnormalities correlate with regional defects noted 
on preoperative perfusion scintigraphy or with perioperative 
ischemic events? Intraoperative transesophageal echocar-
diography in association with scintigraphic findings again 
presents a potential response to this and related questions. 
Perfusion scintigraphy performed with dynamic exercise 
has also been demonstrated to be an excellent test of 
coronary prognosis (14,15). Here the link between perfusion 
defects and ischemic events appears to be myocardium at 
ischemic risk. When it occurs spontaneously weeks to 
months after exercise perfusion scintigraphy, acute myocar-
dial infarction has been shown (16) to occur in regions of 
previously documented stress-induced scintigraphic isch-
emia (reversible defects). Whether such a segmental corre-
lation exists between preoperative dipyridamole-induced 
perfusion defects and regions affected by perioperative 
ischemic events has not been previously investigated. 
Objective. In this preliminary study, we sought to relate 
findings on preoperative dipyridamole perfusion scintigra-
phy to the presence and segmental location of myocardium 
demonstrating ischemia on intraoperative two-dimensional 
transesophageal echocardiography in a clinically high risk 
subset of patients evaluated before they underwent periph-
eral vascular or other noncardiac surgery. We also related 
scintigraphic evidence of potential risk and transesophageal 
echocardiographic evidence of manifest risk to clinical evi-
dence of perioperative ischemic events. 
Methods 
Patient selection. We sought to evaluate and compare the 
findings on preoperative dipyridamole perfusion scintigra-
phy with those on intraoperative transesophageal echocar-
diography in 27 consecutive patients having preoperative 
evaluation because of high coronary risk. Imaging findings 
were related to perioperative ischemic events. Patients were 
selected for the study on the basis of the presence of one or 
more of the following: a history of prior myocardial infarc-
tion; a history of atypical chest pain or typical angina 
pectoris or an abnormal electrocardiogram (ECG) with ST-T 
wave abnormalities suggestive of ischemia or Q waves 
~0.04, consistent with prior myocardial infarction. Patients 
with left ventricular hypertrophy or left bundle branch block 
were included if they presented with one of the listed 
criteria. An ischemic ST-T wave abnormality was defined as 
horizontal or downsloping ST segment depression ~ 1 mm 
beyond the isoelectric baseline, symmetric deep T wave 
inversion in the absence of left ventricular hypertrophy, left 
bundle branch block, an electrolyte abnormality or the use of 
digoxin. Before enrollment in this study, each patient signed 
informed consent approved by the University of California, 
San Francisco Committee on Human Research. In each 
case, imaging findings were related to perioperative ischemic 
events. 
Testing sequence. Preoperative testing was performed 
within 1 week of surgery and included dipyridamole perfu-
sion scintigraphy and a 12-lead ECG. Intraoperative trans-
esophageal echocardiograms were performed and analyzed 
by experienced readers, trained and supervised by the 
laboratory director. Electrocardiograms were monitored 
from the time of intubation to the time just preceding 
extubation. According to an established intraoperative pro-
tocol, intravenous nitroglycerin was administered when new 
segmental wall motion abnormalities were observed. Post-
operative testing included a daily 12 lead ECG and creatine 
kinase MB isoenzyme determination on postoperative days 1 
to 4. 
Twenty-six patients had surgery. Surgical procedures 
generally involved the peripheral vasculature: 11 patients 
had aortofemoral or aortoiliac bypass grafting or thromboen-
darterectomy, 9 had thoracoabdominal aortic aneurysm or 
abdominal aortic aneurysm resection, 4 had femoropopliteal 
or ileofemoral bypass or thromboendarterectomy, 1 patient 
had aortovisceral thromboendarterectomy and 1 had trans-
metatarsal amputation. 
Dipyridamole perfusion scintigraphy. Dipyridamole per-
fusion scintigraphy was performed with informed consent 
according to an adaptation of the protocol of Leppo et al. (8). 
Intravenous dipyridamole (Boehringer-Ingelheim) was ad-
ministered to the supine patient at a rate of 0.14 mg/min for 
4 min with continuous monitoring of symptoms, blood 
pressure and the 12-lead ECG. Three minutes later, 2 to 
3 mCi of thallium-201 was injected intravenously. Five to 
7 min later, planar imaging was performed in the anterior and 
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Figure 1. Intraoperative transesoph- w-g 
ageal echocardiograms. The short-axis 
view of the left ventricle at the level of 
the papillary muscles shows normal 
segmental wall motion at baseline (left) 
and the development of inferior wall 
akinesia (arrows) during surgery 
(right). A = anterior; I = inferior; S = 
septal region. 
30°, 45° and 60° left anterior oblique and left lateral projec-
tions, with use of a high sensitivity collimator applied to a 
Pho Gamma V (Siemens) scintillation camera. In each case, 
the anterior projection was taken to 300,000 counts with 
subsequent images taken to isotime. Images were computer 
enhanced according to an established deblurring algorithm 
(17) to remove the effects of scattered radiation. Late in the 
study single photon emission computed tomographic 
(SPECT) imaging was pelformed with use of a 180° orbit and 
32 to 40 s stops on an orbiter camera (Siemens). SPECT 
imaging was always accompanied by a planar study acquired 
in three projections. Parenteral aminophylline was adminis-
tered, long after thallium administration, only when discom-
forting or threatening side effects occurred. Redistribution 
images were obtained approximately 4 h later. 
Images were qualitatively analyzed by two independent 
observers without knowledge of the clinical outcome, with 
each set of planar images divided into five segments: ante-
rior, inferior, septal, lateral and apical. Similar segments 
were identified on the short-axis and vertical and horizontal 
long-axis SPECT images. Each segment was classified as 
normal or abnormal on the basis of the initial set of images 
and was related to the general distribution of coronary blood 
supply, where anterior or septal defects were related to left 
anterior descending artery disease, lateral defects to left 
circumflex artery disease and inferior defects to right coro-
nary artery disease. An apical segmental defect could be 
related to any vascular territory. Delayed images were 
assessed and abnormal segments were then classified as 
reversible or fixed. 
Two-dimensional transesopbageal ecbocardiograpby. A 
3.5 MHz esophageal transducer system was employed, 
consisting of 32 quartz elements mounted on a gastroscope 
(Diasonics) (18). The gastroscope fiber optics had been 
replaced by wires connected to the transducer, which was 
35 mm long, 15 mm wide, and 16 mm thick. The transducer 
was coupled to an ultrasonagraph (Diasonics 3400, CV 60 or 
CV 6400) with the system providing a 90° sector scan of an 
area I to 20 cm in front of the transducer (18). After 
induction of anesthesia and tracheal intubation, the trans-
ducer was inserted through the mouth and advanced into the 
esophagus, 35 to 40 cm from the incisors. The transducer 
was then advanced past the left atrium and positioned behind 
the inferior wall of the left ventricle, to provide a short-axis 
cross-sectional view at the level of the mid-papillary muscles 
(Fig. I). In these early transesophageal studies, no other 
transducer angulation was available. The apical segment was 
not visualized and therefore was not included in the image 
analysis of either scintigraphic or ultrasound data. The 
transducer was withdrawn before extubation. Transesoph-
ageal images were continuously monitored and videotape 
recordings were made before skin incision, at 15 min inter-
vals during surgery and at any other time when wall motion 
abnormalities were observed. For the purposes of this study, 
all transesophageal echocardiograms were read by two of the 
expert observers who participated in their acquisition and 
who had no knowledge of patient identity, the results of 
other studies or clinical outcome. 
Segmental wall motion was read as normal, hypokinetic, 
akinetic or dyskinetic in the anterior, septal, lateral or 
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inferior segments according to laboratory standards (19). 
Reproducibility in the assessment of wall motion using both 
transthoracic and transesophageal methods has been estab-
lished in both this study and those of others (19-23). 
Sequential changes in wall motion were specifically recorded 
to determine whether abnormalities were transient or per-
manent. 
Data analysis and statistics. The segmental results of 
preoperative dipyridamole perfusion scintigraphy were com-
pared with the results of intraoperative two-dimensional 
transesophageal echocardiography to determine their rela-
tion. In addition, preoperative scintigraphic results and the 
results of intraoperative echocardiography were correlated 
with clinical outcome during the in-hospital perioperative 
recovery period. Events included cardiac death, myocardial 
infarction, ischemic pulmonary edema, and unstable angina. 
A total of 104 segments were analyzed on preoperative 
dipyridamole perfusion scintigrams and compared with the 
same segments on two-dimensional echocardiography. The 
presence of a reversible perfusion was considered to repre-
sent myocardium at ischemic risk and the presence of a new 
related echocardiographic wall motion abnormality was con-
sidered to represent manifest intraoperative ischemia. The 
relation of reversible segmental scintigraphic defects to 
induced echocardiographic wall motion abnormalities was 
assessed with McNemar's test. The intergroup differences in 
patient age, gender, history of infarction, coronary risk 
factors, indexes of surgical risk and the presence or absence 
of a perfusion defect or wall motion abnormality were tested 
with Fisher's exact test for their relation with the rate of 
subsequent events. The null hypothesis was rejected if the 
probability of error was <5%. 
Results 
Study patients. During the study one patient was diverted 
from vascular surgery to coronary angiography and eventual 
coronary bypass surgery because of mUltiple reversible 
scintigraphic abnormalities. The study group then consisted 
of the 26 remaining subjects. • 
Relations among patients. Figure 2 is a schematic flow 
chart of data from the 26 patients and Figure 3 traces 
changes in the myocardial segments. In 15 (58%) of the 26 
patients there was preoperative evidence of myocardium at 
ischemic risk; 29 segments demonstrated a reversible perfu-
sion defect. New segmental wall motion abnormalities, 
indicative of induced myocardial ischemia, were evident on 
transesophageal echocardiography in 11 (42%) of the 26 
patients. Nine (81 %) of these 11 patients also had a preoper-
ative reversible perfusion defect, compared with only 6 
(39%) of 15 patients without a new wall motion abnormality 
(p < 0.05). A new intraoperative wall motion abnormality 
was present in 9 (60%) of the 15 patients with a reversible 
perfusion defect, but in only 2 (18%) of 11 patients without 
preoperative evidence of myocardium at risk (p < 0.05). 
Four of the six patients with a reversible perfusion defect in 
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Figure 2. Comparison of results of preoperative thallium perfusion 
scintigraphy, intraoperative two-dimensional transesophageal echo-
cardiography and clinical outcome in 26 patients undergoing periph-
eral vascular surgery. Ant. = anterior; C+ and C- = presence and 
absence, respectively, of cardiac complication; Inf. = inferior; Lat. 
= lateral; M.1. = myocardial infarction; Pulm. = pulmonary; R + 
and R - = presence and absence, respectively, of a reversible 
perfusion defect; SWMA + and SWMA - = presence and absence, 
respectively, of a segmental wall motion abnormality. 
the absence of an assessed intraoperative wall motion ab-
normality had an additional apical scintigraphic defect that 
was neither viewed nor analyzed on echocardiography. All 
echocardiographic abnormalities that appeared during intra-
operative monitoring were transient, resolving on subse-
quent image evaluation. Figure 4 illustrates a representative 
reversible scintigraphic defect corresponding to the transient 
wall motion abnormality evident on the echocardiogram in 
Figure 1. 
Relations among segments. There were 14 new, transient 
segmental wall motion abnormalities among the 11 patients 
so affected. A new segmental wall motion abnormality was 
present in at least one of the same segments with a reversible 
perfusion defect in each of nine such patients. Overall, 
however, a new wall motion abnormality was present in 9 
(31%) of 29 segments with a reversible perfusion defect; only 
Figure 3. Comparison of regional findings on preoperative dipyrida-
mole perfusion scintigraphy and intraoperative two-dimensional 
transesophageal echocardiography performed on 104 myocardial 
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Figure 4. Same patient as in Fig-
ure I. Preoperative scintigrams. 
Perfusion images obtained imme-
diately after dipyridamole infusion 
(top) and at redistribution 4 h later 
(bottom) are shown in antenor 
(ANT) and (from left to right) 30°, 
45° and 60° left anterior oblique 
(LAO) projections. A largely re-
versible inferior and lateral perfu-
sion defect is seen, corresponding 
to the related induced wall motion 
abnormality shown in Figure I. 
5 (7%) among 75 segments without a reversible perfusion 
defect had a new wall motion abnormality on transesoph-
ageal echocardiography (p < 0.05). None of the latter 
occurred in patients with perioperative events. Nine (64%) 
of 14 new wall motion abnormalities occurred in segments 
with a reversible perfusion defect; only 20 (22%) of 90 
segments without an induced echocardiographic abnormality 
occurred in segments with an induced perfusion abnormality 
(p < 0.05). The presence or absence of reversible scinti-
graphic defects and transient transesophageal echocardio-
graphic wall motion abnormalities was concordant in 79 
(76%) of 104 segments. 
Perioperative events. In 5 (33%) of 15 patients with a 
reversible perfusion defect, there were significant cardiac 
complications including myocardial infarction (with one 
death) in 3 patients, ischemic pulmonary edema and unstable 
angina pectoris. However, only 1 (9%) of 11 patients without 
a preoperative perfusion defect had a perioperative event 
(p = 0.14). Five of six patients with a perioperative event 
had an induced perfusion abnormality. Three of these 6 
patients, each with an induced perfusion abnormality, had an 
induced wall motion abnormality, but 8 of 11 patients with an 
induced wall motion abnormality had no related events. 
Three patients among 15 with a normal intraoperative echo-
cardiographic study had a perioperative event as well; 2 of 
the 3 had an induced perfusion abnormality. Therefore, a 
perioperative event was present in 3 of 11 patients with and 
in 3 of 15 patients without an induced wall motion abnormal-
ity (p = NS). An apparently fixed perfusion defect in three 
patients was related in two patients to a transient wall 
motion abnormality and in the other to an associated event. 
The latter patient was the only patient without a reversible 
perfusion defect to experience cardiac complication (isch-
emic pulmonary edema). Neither age, Dripps-American Sur-
gical Association Index (24), Goldman Multifactorial Index 
(25) nor the total number of perfusion defects (1.7 ± 1.2 vs. 
0.95 ± 1.1) were predictors of events. 
Discussion 
The study in perspective. Dipyridamole perfusion scintig-
raphy is a valuable method for both making the diagnosis and 
estimating the prognosis of coronary artery disease in pa-
tients who cannot undergo dynamic exercise evaluation 
(1-12). Since defects on dipyridamole perfusion scintigraphy 
are generally related to induced heterogeneity of coronary 
blood supply rather than alterations in flow demand, they are 
rarely accompanied by ischemia (26,27). Such defects rep-
resent myocardium at theoretical risk in the clinical setting 
where demands exceed the potential supply. Because the 
patients studied are relatively limited in activity, such stress 
often comes only with an imposed intervention such as 
surgery. With use of intraoperative transesophageal echo-
cardiographic assessment of myocardial wall motion (13), 
preoperative scintigraphic evidence of myocardium at isch-
emic risk can be compared with the area of surgically 
induced ischemia. Do such surgically induced wall motion 
abnormalities correlate with regional defects noted on pre-
operative perfusion scintigraphy or with perioperative isch-
emic events? To more completely assess dipyridamole scin-
tigraphy-related risk in the present study, we compared 
preoperative scintigraphic evidence of myocardium at poten-
tial ischemic risk to functional evidence of intraoperative 
ischemia and manifest perioperative risk. 
The value of perfusion defects. Consecutive patients eval-
uated scintigraphically owing to their high clinical coronary 
risk were studied before noncardiac surgery. Employed 
currently as a screening test for coronary risk, dipyridamole 
perfusion scintigraphy was highly investigational at the time 
of this study. Most patients continued on to noncardiac 
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surgery even in the setting of a reversible preoperative 
defect. Similar to other findings (7-11), perioperative events 
occurred generally in patients with scintigraphic evidence of 
myocardium at ischemic risk. The rate of cardiac complica-
tions in the group with reversible perfusion abnormalities 
was 3.7 times higher than in the group without such defects. 
Of patients with a reversible perfusion defect on preopera-
tive perfusion scintigraphy, 33% developed a significant 
perioperative cardiac complication. However, this trend 
relating preoperative reversible perfusion defects to periop-
erative events did not reach significance in this preliminary 
study, probably owing to sample size. The trend relating 
events to the number of reversible defects suggests a poten-
tial for risk stratification among patients with reversible 
defects. The presence or absence of preoperative reversible 
perfusion abnormalities related closely but not entirely to 
intraoperative transient wall motion abnormalities. 
Intraoperative wall motion abnormalities. Alterations in 
left ventricular function indicative of ischemia and mani-
fested by abnormalities on transesophageal echocardiog-
raphy have been noted in almost 50% of patients at high risk 
having major peripheral vascular surgery (22). Transient 
intraoperative wall motion abnormalities were also frequent 
in the present study. 
Most intraoperative wall motion abnormalities occurred 
in patients and segments with induced preoperative perfu-
sion abnormalities and, conversely, most segments without 
reversible perfusion abnormalities were unrelated to intra-
operative wall motion abnormalities. Overall, perfusion de-
fects and wall motion abnormalities correlated in 76% of 104 
analyzed segments. 
However, the frequency of peri operative events was not 
significantly greater among patients with new wall motion 
abnormalities on transesophageal echocardiography (27%) 
than among those without such induced abnormalities (20%). 
If intraoperative wall motion abnormalities are the manifes-
tation of potential preoperative risk identified scintigraphi-
cally, these results may at first appear unexpected. Alterna-
tively, however, the similar frequency could simply relate to 
the known variability in the ischemic response to varying 
stress, the relatively small numbers involved or the influence 
of the effects of intraoperative nitroglycerin and subsequent 
treatment. The latter might also have blunted the appearance 
of further wall motion abnormalities and delayed the occur-
rence of events. 
Again, new intraoperative wall motion abnormalities and, 
of course, perioperative events were relatively infrequent 
even among segments with a reversible perfusion abnormal-
ity. These findings likely illustrate the uncertainty of events 
even when related to reversible scintigraphic abnormalities 
and myocardium at ischemic risk, and again suggest the 
possible effects of therapy. The data are also consistent with 
prior studies (7-9). 
Another interesting finding relates to the reversibility of 
all intraoperative wall motion abnormalities. If not missed 
by ultrasound study (as discussed later), both the events and 
their functional precursors occurred late in the postoperative 
course of these study patients, after the time of transesoph-
ageal monitoring. Because transesophageal monitoring was 
discontinued before extubation, events appeared related to 
the stress of extubation imd the postanesthetic period. Their 
occurrence in the postoperative period is in parallel with 
other studies (28,29) and seems related to the relatively 
unmonitored period of progressive ambulation, the effects of 
intermittently increased sympathetic outflow of the uncon-
trolled recovery period and the stress associated with mobi-
lization of sequestered fluids and possible changes in the 
clotting system (28-31). 
Technical considerations and study limitations. Previous 
evaluation of interobserver and intraobserver variability in 
the assessment of intraoperative wall motion on transesoph-
ageal echocardiography has shown excellent agreement, in 
the range of 900/0-95% (19-21,23). The original segmental 
analysis that served as the basis for intraoperative treatment 
was related with good agreement to the readings performed 
for the study, with no significant difference. The finite 
sensitivity of the ultrasound method, possibly reduced in the 
operative setting, may playa role in the findings presented. 
The transient nature of segmental wall motion abnormalities 
relieved by nitroglycerin strongly suggests that their cause is 
ischemia. 
An apical perfusion defect occurred in four patients with 
negative transesophageal echocardiographic studies. In this 
early period of method application, the apical segment was 
not imaged with transesophageal echocardiography, but it 
was the primary location of perfusion abnormality in these 
patients. This omission may explain, in part, the discrepan-
cies in functional and perfusion findings, the reason for 
echocardiographic insensitivity in segments with previously 
induced perfusion defects and the relative insensitivity of the 
functional method to perioperative events. The addition of a 
four-chamber transesophageal echocardiogram would aid 
assessment in the apical segment. Further, the difference in 
image presentation between planar scintigraphic evaluation 
and the four quadrants of the short-axis echocardiogram, 
and the potential difficulties in their comparison, must be 
appreciated. 
Occasionally, an intraoperative wall motion abnormality 
was seen in segments related to a fixed perfusion defect. 
While the latter was interpreted as evidence of scarring, 
recent studies (32) suggest that some viable segments at 
ischemic risk will not demonstrate reversibility for 24 h. 
Failure to perform such delayed imaging and the underesti-
mation of viable myocardium at ischemic risk may provide 
another reason for the discrepancy between preoperative 
perfusion and intraoperative function. The more global im-
plementation of SPECT imaging might also be advantageous 
owing to the increased sensitivity of this method (33). 
Notable was the relatively small sample size, which 
stemmed from the restrictive patient qualifications and the 
growing trend to perform revascularization in patients with a 
reversible perfusion defect. 
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Implications of the study. Although a trend was apparent 
in the relation between preoperative reversible perfusion 
defects and coronary events, significance was not estab-
lished as it has been by others. This difference may relate to 
the small and selected patient group in our study. This 
relation was not our primary focus. Most important was the 
identification of a relation between preoperative reversible 
perfusion defects and new intraoperative wall motion abnor-
malities. The latter, serving as a marker of induced ischemia, 
identified another component of related ischemic risk. 
Preoperative dipyridamole thallium perfusion defects 
have been shown to represent potential ischemic risk. It 
would appear that induced intraoperative segmental wall 
motion abnormalities are another manifestation of this risk. 
Although only 33% of patients had a reversible perfusion 
abnormality on preoperative assessment, 60% of patients 
with a reversible perfusion defect had an associated intraop-
erative wall motion abnormality. Despite technical factors 
that tended to minimize the relation, the exten~ of the 
relation between segments with preoperative reversible per-
fusion defects and intraoperative wall motion abnormalities 
suggests a greater extent of intraoperative ischemia and risk 
related to preoperative reversible perfusion defects than 
would be perceived from the perioperative event rate alone. 
That all segments potentially at risk do not manifest their 
risk intraoperatively, and that all segments demonstrating 
potential or manifest risk do not predict events, may relate to 
care taken in preoperative, intraoperative and postoperative 
anti-ischemic management. It is tempting to suggest that the 
link between perioperative perfusion defects and postoper-
ative events is in the higher observed incidence of induced 
intraoperative ischemia. However, the lack of an increased 
event rate among those patients with, compared with those 
without, intraoperative wall motion abnormalities fails to 
support this conclusion. Similarly, the study does not sup-
port the prognostic value of induced intraoperative wall 
motion abnormalities or the value of treating them. In fact, 
induced wall motion abnormalities and peri operative events 
may be based on different mechanisms affecting myocardium 
at ischemic risk at different times in the peri operative 
course. A controlled study randomizing patients with new 
intraoperative segmental wall motion abnormalities into 
treatment and non treatment groups could be important. 
This study was designed to assess the relation ofpreoper-
ative perfusion and intraoperative wall motion. We could 
not, nor would we at the time of this study, seek to control 
intraoperative treatment of apparent ischemia. However, 
such treatment probably did affect results and must be 
factored into our conclusions. Similarly, we focused on an 
in-depth evaluation of imaging findings in surgical patients at 
high risk. Although during the study period many patients 
had surgery without such evaluation, it was not our present 
purpose to assess the relative benefits of scintigraphic as-
sessment and transesophageal echocardiographic monitoring 
by comparing patients with and without these studies. 
Conclusions. These findings support previous data re-
garding the relation between preoperative reversible perfu-
sion defects and perioperative ischemic events. Induced 
intraoperative wall motion abnormalities occur in myocar-
dial segments with an induced preoperative perfusion defect 
in many patients and would appear to identify another and 
more frequent manifestation of ischemic risk. Possibly ow-
ing to the small numb~r of patients thus far evaluated or to 
other factors, a clear relation among intraoperative evidence 
of ischemic risk, new wall motion abnormalities and peri-
operative events cannot be documented. The value of intra-
operative echocardiography and the potential benefits of 
treatment directed specifically at new intraoperative wall 
motion abnormalities in patients with reversible abnormali-
ties on preoperative perfusion scintigraphy should be further 
assessed. 
We express our great appreciation for the typing and editorial skills of Terry 
Olesen and Claudia Braun both here and in other efforts. 
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